Government Offers Interest Waiver If Pharma Companies Agree To Pay Rs 3,500 Crore, Drop All 666 Lawsuits
In A First, Kerala Sets Up Drug Price Monitoring And Research Unit To Curb Overcharging Of Medicines
Incentivising Innovation: No Price Controls On New Drugs For First Five Years
Indian Stents ‘Equally Good’ As The Best In The Market, Study Rubbishes Claims Of Superiority By Foreign Manufacturers
Dilemma Of The Draft Pharma Policy: To Protect The Consumer Or Promote Industry?
